Edition:
India

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

37.09USD
20 Jul 2018
Change (% chg)

$0.13 (+0.35%)
Prev Close
$36.96
Open
$36.96
Day's High
$37.21
Day's Low
$36.29
Volume
41,411
Avg. Vol
68,048
52-wk High
$45.61
52-wk Low
$15.37

Chart for

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $702.77
Shares Outstanding(Mil.): 30.68
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates